Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Reyes (Santiago, Chile), V. Wolff (Santiago, Chile), L. Alberti (Buenos Aires, Argentina), E. Juarez (Mexico DF, Mexico), V. Leiva (Santiago, Chile), L. Fassola (Buenos Aires, Argentina), M. Mejia (Mexico DF, Mexico), I. Buendia (Mexico DF, Mexico), F. Caro (Buenos Aires, Argentina), J. Rojas Serrano (Mexico DF, Mexico), F. Paulin (Buenos Aires, Argentina), M. Florenzano (Santiago, Chile). Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies. 4744

Member's Comments

No comment yet.

Related content which might interest you: Variables associated with functional improvement in patients with interstitial lung disease and myositis related antibodies: Results from a multicentric Latin American study. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Treatment dilemmas in sarcoidosis - a retrospective cohort study Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001 Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients Source: International Congress 2014 – Sarcoidosis Year: 2014 Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study Source: International Congress 2014 – Sarcoidosis Year: 2014 Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe. Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 Interstitial lung diseases in children: The French national cohort study Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Thyroid disease in an Irish cohort of sarcoidosis patients Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Treatment of patients with idiopathic pulmonary fibrosis in real-life setting: Results from the Latin American Pulmonary Fibrosis Registry REFIPI Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 A case series of eight patients treated with alectinib including a case of interstitial lung disease Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014